Mann, Sharon G.

HRN: 29-06-36  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/25/2026
06/01/2026
IV
2.25 G
Q6H
Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines